AT234100T - Medicines for topical use of sexual hormones for treating the dry eye, and method for the production and use thereof - Google Patents

Medicines for topical use of sexual hormones for treating the dry eye, and method for the production and use thereof

Info

Publication number
AT234100T
AT234100T AT91917537T AT91917537T AT234100T AT 234100 T AT234100 T AT 234100T AT 91917537 T AT91917537 T AT 91917537T AT 91917537 T AT91917537 T AT 91917537T AT 234100 T AT234100 T AT 234100T
Authority
AT
Austria
Prior art keywords
use
medicines
treating
production
method
Prior art date
Application number
AT91917537T
Other languages
German (de)
Inventor
Virginia Lubkin
Original Assignee
Virginia Lubkin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Lubkin filed Critical Virginia Lubkin
Priority to PCT/US1991/005863 priority Critical patent/WO1993003731A1/en
Publication of AT234100T publication Critical patent/AT234100T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/912Ophthalmic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/912Ophthalmic
    • Y10S514/914Inflammation
AT91917537T 1991-08-17 1991-08-17 Medicines for topical use of sexual hormones for treating the dry eye, and method for the production and use thereof AT234100T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US1991/005863 WO1993003731A1 (en) 1991-08-17 1991-08-17 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application

Publications (1)

Publication Number Publication Date
AT234100T true AT234100T (en) 2003-03-15

Family

ID=22225745

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917537T AT234100T (en) 1991-08-17 1991-08-17 Medicines for topical use of sexual hormones for treating the dry eye, and method for the production and use thereof

Country Status (8)

Country Link
US (1) US5041434A (en)
EP (1) EP0652754B1 (en)
AT (1) AT234100T (en)
DE (3) DE69133214T2 (en)
DK (1) DK0652754T3 (en)
ES (1) ES2086268T3 (en)
GR (1) GR960300027T1 (en)
WO (1) WO1993003731A1 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4038128A1 (en) * 1990-11-27 1992-06-04 Schering Ag 8-ene-19, 11 (beta) -ueberbrueckte steroids, their production and pharmaceutical compositions containing them
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
US5352445A (en) * 1992-05-07 1994-10-04 Lavaux Joseph E Lavaux tear test lacrimal equilibration time (LET)
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
WO1994004155A1 (en) * 1992-08-19 1994-03-03 Health Resource Institute, Ltd. Dehydroepiandrosterone therapy for the treatment of eye disorders
US5639743A (en) * 1992-11-13 1997-06-17 University Of Georgia Research Foundation Compositions and methods for treating exocrine gland atrophy
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
AUPO427196A0 (en) * 1996-12-19 1997-01-23 University Of Sydney, The A method for preventing or controlling cataract
ZA9809513B (en) 1997-10-21 1999-04-21 Alcon Lab Inc Compositions containing histamine H2 agonists and methods of use in treating dry eye
US6096733A (en) * 1998-12-10 2000-08-01 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
WO2000038663A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
WO2001034615A1 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
PT1227809E (en) 1999-11-09 2005-06-30 Alcon Inc Analogs of 15-hydroxyethythetraenoic acid interrupted by a heteroatomy and methods of utilization
US6552084B2 (en) 1999-11-09 2003-04-22 Alcon Universal Ltd. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
JP2003514782A (en) 1999-11-09 2003-04-22 アルコン,インコーポレイテッド Lipoxin A4 and analogs thereof for treatment of dry eye
PL355998A1 (en) 1999-11-09 2004-05-31 Alcon Inc. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
US6331644B1 (en) 1999-11-09 2001-12-18 Alcon Universal Ltd. 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use
WO2001034552A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
WO2001034553A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
JP2003513947A (en) 1999-11-09 2003-04-15 アルコン,インコーポレイテッド 15-Hydroxyeicosatetraene compound and use thereof
AT257144T (en) 1999-11-09 2004-01-15 Alcon Inc Omega chain-modified hydroxyeicosatetraenic acid derivatives used in the treatment of the dry external disease
US6458854B2 (en) 1999-11-09 2002-10-01 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
AU776187B2 (en) 1999-11-09 2004-09-02 Alcon Inc. Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
US6803385B2 (en) 1999-11-09 2004-10-12 Alcon, Inc. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
WO2001034550A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
US6576663B2 (en) 1999-12-22 2003-06-10 Alcon, Inc. 6-Keto prostaglandin F1α and analogs for treating dry eye
MXPA03003585A (en) * 2000-11-14 2003-07-14 Vital Health Sciences Pty Ltd Complexes of phosphate derivatives.
PL367286A1 (en) 2001-05-21 2005-02-21 Alcon, Inc. Use of nfkb inhibitors to treat dry eye disorders
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
JP2004531560A (en) * 2001-05-21 2004-10-14 アルコン,インコーポレイテッド How to treat dry eye disorders
EP1392355B1 (en) 2001-05-21 2007-02-14 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US6750250B1 (en) 2001-07-12 2004-06-15 Alcon, Inc. 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
JP4745608B2 (en) * 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド Skin treatment using phosphoric acid derivatives of electron transfer agents
WO2003028667A2 (en) * 2001-10-04 2003-04-10 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
JP2005505592A (en) * 2001-10-11 2005-02-24 アルコン,インコーポレイテッド Method for treating dry eye by a combination of an anti-inflammatory steroid and a MUC-1 secretagogue
US20030109488A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
US20030109508A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
AT487456T (en) * 2001-12-13 2010-11-15 Vital Health Sciences Pty Ltd Transdermal transport of connections
US6659985B2 (en) 2002-01-30 2003-12-09 Southern College Of Optometry Method to use transdermal administration of androgens to the adnexa of the eye
US20070213310A1 (en) * 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents
WO2004069248A1 (en) * 2002-12-09 2004-08-19 University Of Florida Prodrugs for use a ophthalmic agents
US7186707B2 (en) 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7026296B2 (en) * 2002-09-20 2006-04-11 Alcon, Inc. Methods of treating dry eye disorders
AU2003290776A1 (en) * 2002-11-15 2004-06-15 Panaseca, Inc. Methods and compositions for alleviating dry eyes
WO2004060274A2 (en) * 2002-12-20 2004-07-22 Alcon, Inc. Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
WO2004093878A1 (en) * 2003-04-16 2004-11-04 Alcon, Inc. Use of fused pyridazine derivatives for treating dry eye disorders
DK1720551T3 (en) * 2004-03-03 2011-05-16 Vital Health Sciences Pty Ltd Alkaloidformuleringer
ES2435398T3 (en) 2004-04-08 2013-12-19 Eye Co Pty Ltd. Exudative retinopathy treatment with mineralocorticoids
CN100522147C (en) * 2004-05-14 2009-08-05 爱尔康公司 Application of 5, 6, 7-tri-hydroxy enanthic acid and analog thereof for treating dry eye disorders and uveitis
US7923471B2 (en) * 2004-05-14 2011-04-12 Alcon, Inc. Method of treating dry eye disorders and uveitis
US7223737B1 (en) 2004-08-13 2007-05-29 Alcon, Inc. Method of treating dry eye disorders using glycosides
WO2006065916A1 (en) * 2004-12-14 2006-06-22 Alcon, Inc. Method of treating dry eye disorders using 13(s)-hode and its analogs
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
EP1858523A1 (en) * 2005-03-02 2007-11-28 Nascent Pharmaceutical, Inc. Combinaion therapy for topical application in the treatment of dry eye syndrome
US20090233881A1 (en) * 2005-03-03 2009-09-17 Vital Health Sciences Pty. Ltd Compounds having anti-cancer properties
US7718635B2 (en) 2005-06-10 2010-05-18 Pola Chemical Industries Inc. Triterpenic acid derivative and preparation for external application for skin comprising the same
EP1893159B1 (en) * 2005-06-17 2015-09-30 Vital Health Sciences Pty Ltd. A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents
JP2009520697A (en) * 2005-12-23 2009-05-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド Compounds having cytokine regulatory properties
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
SI1854477T1 (en) 2006-03-16 2017-01-31 Dyax Corp. Peptides inhibiting plasma kallikrein for use in the treatment of ophthalmic disorders.
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
WO2008109780A1 (en) * 2007-03-06 2008-09-12 University Of Louisville Research Foundation, Inc Methods and compounds for the targeted delivery of agents to bone for interaction therewith
EP2129373B1 (en) 2007-04-02 2013-05-22 DSM IP Assets B.V. Use of genistein for treating dry eye syndrome
RU2445098C2 (en) * 2007-07-11 2012-03-20 Пфайзер Инк. Pharmaceutical composition and methods of treating dry-eye syndrome
US20090098136A1 (en) * 2007-10-15 2009-04-16 Alcon Research, Ltd. Use of tnf receptor antagonists for treating dry eye
TW200927192A (en) * 2007-11-19 2009-07-01 Alcon Res Ltd Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
US8207226B1 (en) 2008-06-03 2012-06-26 Alcon Research, Ltd. Use of FAAH antagonists for treating dry eye and ocular pain
US20120041195A1 (en) 2009-02-13 2012-02-16 Fovea Pharmaceuticals Heterocyclic compounds
BR112012010586A2 (en) 2009-11-06 2016-03-22 Alcon Res Ltd Nutritional supplements for safe eye relief.
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
NZ602572A (en) 2010-03-30 2014-11-28 Phosphagenics Ltd Transdermal delivery patch
TW201204723A (en) 2010-06-22 2012-02-01 Fovea Pharmaceuticals Heterocyclic compounds, their preparation and their therapeutic application
US20120079612A1 (en) * 2010-09-24 2012-03-29 West Virginia University Dry eye animal model
NZ615410A (en) 2011-03-15 2015-08-28 Phosphagenics Ltd New composition suitable for the treatment of inflammation and/or infection in breast or udder tissue
US10507245B2 (en) * 2012-07-19 2019-12-17 Luis Felipe Vejarano Restrepo Ophthalmic formulation and method for ameliorating presbyopia
US20190177407A1 (en) 2016-06-20 2019-06-13 Novartis Ag Methods of treating dry eye disease using tnf alpha antagonists

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
FR3331M (en) * 1963-04-09 Leo Ab A medicament containing a steroid hormone derivative.
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
JPS58126810A (en) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd Ophthalmic anti-inflammatory solution and preparation thereof
US4581226A (en) * 1983-04-07 1986-04-08 Dillon Richard S Method of treating sensitive animal tissue with a specially processed seawater solution
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
SE8305864D0 (en) * 1983-10-25 1983-10-25 L E Medical eye drops
US4812448A (en) * 1984-10-22 1989-03-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4617299A (en) * 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4863912A (en) * 1986-05-19 1989-09-05 New York Medical College Use of tetrahydrocortisol in glaucoma therapy
US4774236A (en) * 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
US4861763A (en) * 1986-09-17 1989-08-29 Research Triangle Institute 17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
US4866049A (en) * 1987-08-10 1989-09-12 Spectra Pharmaceutical Services, Inc. Ophthalmic compositionn and method of using same
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US4951683A (en) * 1989-01-19 1990-08-28 Davis Jeffrey P Device for detecting keratoconjunctivitis sicca
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application

Also Published As

Publication number Publication date
DK0652754T3 (en) 2003-06-10
WO1993003731A1 (en) 1993-03-04
ES2086268T3 (en) 2003-11-16
DE69133214T2 (en) 2003-12-18
US5041434A (en) 1991-08-20
GR960300027T1 (en) 1996-05-31
DE652754T1 (en) 1996-09-12
EP0652754A4 (en) 1994-11-09
EP0652754A1 (en) 1995-05-17
ES2086268T1 (en) 1996-07-01
EP0652754B1 (en) 2003-03-12
DE69133214D1 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
DE69434316D1 (en) Process for the preparation of trisubstituted imidazoles with many therapeutic properties
DE59310399D1 (en) Prodrugs, their preparation and use as medicines
DE69528437D1 (en) Substituted azaindolylide derivatives and method for the production thereof
DK0605501T5 (en) Use of presynaptic neurotoxin in the treatment of cerebellar palsy
DE59712560D1 (en) Organically modified aerogeles, method for the production thereof by surface modification of the aqueous gel without previous solvent exchange and containing drying, and their use
DE69529483D1 (en) Absorbent product and method for the production thereof
DE69330347T2 (en) Pth and pthrp analogs their production and use for the treatment of osteoporosis.
DK0858510T3 (en) Process for the preparation of O-acetylserine, L-cysteine and L-cysteine-related products
DE69617654D1 (en) Water-based topical cream containing nitroglycerin, method for the production and use thereof
DE69529054D1 (en) Targeted active substance system, method for the production and use thereof
DE69618769T2 (en) Flat-foldable personal respiratory device and method for their production
DE69528485D1 (en) Biphenyl derivatives, processes for their preparation and their use as medicines
DE69631834D1 (en) New medicine containing an acid-sensitive benzimidazole and method for the production thereof
DE68929373D1 (en) Completely micro-manufactured biosensors and method for the production and use
DE69627816D1 (en) Arachidon acid and method for the production and use thereof
DE69429119T2 (en) Method for producing freezer dried drug dosage forms
DE69723104D1 (en) Piridine-2-yl-methylamine derivatives, method for the production thereof and their use as medicinal products
DE69313908T3 (en) Process for the preparation of modified polysaccharides and modified polysaccharides
DE69623961T2 (en) Camptothecinanalogs, method for the production thereof, their use as medicinal products, and pharmaceutical summary containing them
DE69629238D1 (en) Device for the treatment of sleep apnea by electrostimulation
DE69626961D1 (en) Disposable clothing, method and device for the production thereof
DE69331414D1 (en) Depsipeptide, production and application
DE69428294T2 (en) Loop-type textile fastener, process for its manufacture and process for its treatment
DK0786264T3 (en) Devices for the treatment of pulmonary vasoconstriction and asthma
DE10299043I1 (en) 1-Biphenylimidazole Derivatives Process for their preparation and their therapeutic use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0652754

Country of ref document: EP

REN Ceased due to non-payment of the annual fee